Health-care companies continued to rally on expectations of higher drug prices amid U.S. pharmaceutical shortages.
The Federal Trade Commission is launching a probe into recent shortages of chemotherapies and other drugs, examining the role played by companies that help buy and distribute the bulk of medicines sold to U.S. hospitals.
Cigna…
Master your money.
Subscribe to MarketWatch.
Get this article and all of MarketWatch.
Access from any device. Anywhere. Anytime.
Already a subscriber?
Log In
Read More: Health Care Stocks Pile On Gains — Health Care Roundup